Enhancing Utility of Neuropsychological Evaluation for Earlier and Effective Diagnosis of Dementia in Parkinson's Disease

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe University of Queensland

About this trial

Dementia is observed in 80% of people living with advanced stage Parkinson's disease, however, there are inadequate opportunities for early and effective diagnosis of dementia in current clinical practice. This study aims to identify whether a new tool called PDCogniCare, can improve detection of dementia in people living with Parkinson's disease, and to explore what factors might influence its use in healthcare services.

Eligibility criteria

Qualifiers

People living with idiopathic Parkinson's disease, one year or more post-diagnosis, attending Movement Disorder Clinics

Disqualifiers

People with severe Parkinson's disease who aren't able to communicate

People with comorbid neurological conditions (e.g. Stroke)

Trial design

Treatments tested in this trial

  • PDCogniCare platform

Treatment groups

275 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators

The University of Queensland

Lead sponsor

Medical Research Future Fund

Collaborator

Metro South Health

Collaborator

Metro North Health

Collaborator

Queensland University of Technology

Collaborator

University of Sydney

Collaborator

OPN365

Collaborator

Australian Dementia Network

Collaborator

Dementia Australia

Collaborator

Lions Club of Brisbane Inner North

Collaborator

Parkinson's Queensland

Collaborator